Coronary Artery Bypass Graft Market Size

  • Report ID: 732
  • Published Date: Jun 13, 2025
  • Report Format: PDF, PPT

Coronary Artery Bypass Graft Market Outlook:

Coronary Artery Bypass Graft Market size was over USD 13.73 billion in 2024 and is poised to exceed USD 31.33 billion by 2034, growing at over 8.6% CAGR during the forecast period i.e., between 2025-2034. In the year 2025, the industry size of coronary artery bypass graft is evaluated at USD 14.73 billion.

The primary growth driver of the coronary artery bypass graft market is the rising prevalence of cardiovascular diseases (CVDs) particularly coronary artery disease (CAD). According to the British Heart Foundation, as of 2021, over 250 million people in the world were living with coronary heart disease.

Unhealthy lifestyles, poor dietary habits, smoking, and sedentary behavior have led to a surge in CAD cases, necessitating surgical interventions like coronary artery bypass surgery. Additionally, the growing global elderly population is at higher risk of heart disease, driving demand for CABG procedures. One in six individuals worldwide will be 60 or older by 2030. At this point, there will be 1.4 billion people over 60, up from 1 billion in 2020. The number of individuals in the world who are 60 years of age or older is expected to increase to 2.1 billion by 2050. Between 2020 and 2050, the population of people 80 years of age or older is predicted to triple, reaching 426 million.


Coronary Artery Bypass Graft Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of coronary artery bypass graft is evaluated at USD 14.73 billion.

Coronary Artery Bypass Graft Market size was over USD 13.73 billion in 2024 and is poised to exceed USD 31.33 billion by 2034, growing at over 8.6% CAGR during the forecast period i.e., between 2025-2034.

North America is expected to dominate largest industry share of 49.8% by 2034.

The key market players include Guidant Group, MAQUET Holding B.V. & Co.KG, Novadaq Technologies Inc., KARL STORZ GmbH & Co. KG, Edwards Lifesciences Corporation, Genesee Biomedical Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos